Metformin treatment of antipsychotic-induced dyslipidemia: an analysis of two randomized, placebo-controlled trials

Dyslipidemia is one of the most common adverse effects in schizophrenia patients treated with antipsychotics. However, there are no established effective treatments. In this study, data were pooled from two randomized, placebo-controlled trials, which were originally designed to examine the efficacy...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Mol Psychiatry
Main Authors: Wu, R-R, Zhang, F-Y, Gao, K-M, Ou, J-J, Shao, P, Jin, H, Guo, W-B, Chan, P K, Zhao, J-P
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group 2016
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5078852/
https://ncbi.nlm.nih.gov/pubmed/26809842
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mp.2015.221
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares